Literature DB >> 28757605

The pros and cons of dying tumour cells in adaptive immune responses.

Xiaochen Wang1, Xiao-Jie Lu1, Beicheng Sun1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28757605     DOI： 10.1038/nri.2017.87

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  10 in total

Review 1.  Innate immune recognition of cancer.

Authors:  Seng-Ryong Woo; Leticia Corrales; Thomas F Gajewski
Journal:  Annu Rev Immunol       Date:  2015-01-22       Impact factor: 28.527

Review 2.  Dying cells actively regulate adaptive immune responses.

Authors:  Nader Yatim; Sean Cullen; Matthew L Albert
Journal:  Nat Rev Immunol       Date:  2017-03-13       Impact factor: 53.106

3.  IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity.

Authors:  Seigo Terawaki; Shunsuke Chikuma; Shiro Shibayama; Tamon Hayashi; Takao Yoshida; Taku Okazaki; Tasuku Honjo
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

Review 4.  Molecular and cellular insights into T cell exhaustion.

Authors:  E John Wherry; Makoto Kurachi
Journal:  Nat Rev Immunol       Date:  2015-08       Impact factor: 53.106

5.  Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.

Authors:  Andrea Schietinger; Mary Philip; Varintra E Krisnawan; Edison Y Chiu; Jeffrey J Delrow; Ryan S Basom; Peter Lauer; Dirk G Brockstedt; Sue E Knoblaugh; Günter J Hämmerling; Todd D Schell; Natalio Garbi; Philip D Greenberg
Journal:  Immunity       Date:  2016-08-09       Impact factor: 31.745

6.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

Review 7.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

8.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

9.  Increased antigen presentation but impaired T cells priming after upregulation of interferon-beta induced by lipopolysaccharides is mediated by upregulation of B7H1 and GITRL.

Authors:  Fang Wang; Yan Yan Wang; Juan Li; Xiang You; Xin Hui Qiu; Yi Nan Wang; Feng Guang Gao
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

10.  Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes.

Authors:  Hany M Ibrahim; Ibrahim A El-Elaimy; Heba M Saad Eldien; Badr Mohamed Badr; Danny M Rabah; Gamal Badr
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543
  10 in total
  6 in total

1.  Glutamine deprivation impairs function of infiltrating CD8+ T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis.

Authors:  Wei Wang; Meng-Nan Guo; Ning Li; De-Quan Pang; Jing-Hua Wu
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

2.  Genetic and phenotypic difference in CD8+ T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma.

Authors:  Xiaochen Wang; Qifeng He; Haiyuan Shen; Xiao-Jie Lu; Beicheng Sun
Journal:  J Med Genet       Date:  2018-04-17       Impact factor: 6.318

3.  Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.

Authors:  Rixin Zhang; Tiegang Li; Weiqi Wang; Wenqiang Gan; Silin Lv; Zifan Zeng; Yufang Hou; Zheng Yan; Min Yang
Journal:  Front Oncol       Date:  2020-12-07       Impact factor: 6.244

Review 4.  Cancer Occurrence as the Upcoming Complications of COVID-19.

Authors:  Ilnaz Rahimmanesh; Laleh Shariati; Nasim Dana; Yasaman Esmaeili; Golnaz Vaseghi; Shaghayegh Haghjooy Javanmard
Journal:  Front Mol Biosci       Date:  2022-01-28

Review 5.  Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.

Authors:  Goodwin G Jinesh; Andrew S Brohl
Journal:  Signal Transduct Target Ther       Date:  2022-08-23

Review 6.  Long Noncoding RNAs, New Critical Regulators in Cancer Immunity.

Authors:  Minjie Wu; Peifen Fu; Lei Qu; Jian Liu; Aifu Lin
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.